- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03494829
Physical Activity, Motor Competence, Pulmonary Function, and Quality of Life in Children With Severe Spinal Disease
Study Overview
Status
Detailed Description
Early Onset Scoliosis (EOS) defines patients who develop deformities of the spine and/or thorax in the embryologic development or in the early childhood. The exact prevalence of EOS in Norway is unknown, but it is assumed to be approximately 200-300 new EOS patients every year. EOS is a severe condition, whereby some of the most common and also most severe consequences of the deformity are severe pulmonary problems. The patients may require extensive orthopedic treatment from early childhood and until maturity to avoid serious consequences with severe pulmonary problems and shortening of life.
EOS' secondary problems, including severe consequences on the pulmonary function might contribute to enhanced inactivity. Inactivity contributes to further negative impact on development of the musculoskeletal system, motor competence and pulmonary function. Considering the severity of EOS and children's reduced life expectancy, it is extremely important that EOS children achieve the favorable impact of physical activity during their growth. Insufficient level of activity might worsen the prognosis, thus counteracting the treatment's ambitions. The investigator's aim is to extend the knowledge about level of activity, motor competence, pulmonary function, and health related quality of life in Norwegian children, surgically treated for EOS.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0372
- Oslo University Hospital, Rikshospitalet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Early onset scoliosis diagnosis
- Understand and speak Norwegian
- For physical activity test: Walking ability
- For motor competence test and/or pulmonary function test: Ability to understand the test and cooperate
Exclusion Criteria:
- Other spinal disease, not early onset scoliosis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity, assessed by use of accelerometer
Time Frame: Change in activity counts from baseline to activity counts at 6 months and 12 months.
|
Physical Activity will be measured objective by use of an accelerometer (used over 7 days), recorded as Activity Counts/ minutes
|
Change in activity counts from baseline to activity counts at 6 months and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Airway resistance, assessed by use of plethysmography
Time Frame: Change in measures from baseline and to 12 months
|
Children >8 years will also be assessed by use of plethysmography.
Airway resistance will be measured, recorded as the ratio of driving pressure divided by flow through the airways
|
Change in measures from baseline and to 12 months
|
Pulmonary residual volume and total lung capacity, assessed by use of plethysmography
Time Frame: Change in measures from baseline and to 12 months
|
Children >8 years will also be assessed by use of plethysmography.
Residual volume (liters) and total lung capacity (liters) will be measured.
|
Change in measures from baseline and to 12 months
|
Pulmonary function, assessed by use of diffusion capacity test
Time Frame: Change in measures from baseline and to 12 months
|
Children >8 years will be assessed by use of diffusion capacity test.
Diffusing capacity or transfer factor of the lung for carbon monoxide (CO) (DLCO) will be measured.
|
Change in measures from baseline and to 12 months
|
Pulmonary function, assessed by use of spirometry
Time Frame: Change in measures from baseline and to 12 months
|
All participants will go through spirometry.
Vital capacity (VC), Forced vital capacity (FVC), Forced expiratory volume (FEV) at timed intervals of 0.5, 1.0 (FEV1), 2.0, and 3.0 seconds and maximal voluntary ventilation (MVV) will be measured (liters)
|
Change in measures from baseline and to 12 months
|
Forced expiratory flow, assessed by use of spirometry
Time Frame: Change in measures from baseline and to 12 months
|
All participants will go through spirometry.
Forced expiratory flow 25-75% (FEF 25-75) will be measured (liters/second)
|
Change in measures from baseline and to 12 months
|
Motor competence, assessed by use of Movement Assessment Battery of Children- 2. edition
Time Frame: Baseline and after 12 months
|
Motor competence will be assessed by use of Movement Assessment Battery of Children- 2. edition
|
Baseline and after 12 months
|
Health related quality of life in children
Time Frame: Change in parents answers of health related quality of life of their child from baseline, to 6 months and to 12 months.
|
Health related quality of life will be assessed by use of the Early Onset Scoliosis 24-item Questionnaire (EOSQ-24).
Total score, ranged 0 (worst) to 100 (best), including 11 subdomain scores, ranged 0 (worst) to 100 (best) will be calculated.
|
Change in parents answers of health related quality of life of their child from baseline, to 6 months and to 12 months.
|
Health related quality of life in adolescents
Time Frame: Change in subjective answers of health related quality of life from baseline, to 6 mounts and to 12 mounts.
|
Among participants > 16 years, health related quality of life will be assessed by use of the Scoliosis Research Society 22- item (SRS-22) questionnaire.
Total score and 5 subdomain scores, all ranged 5 (best) to 1 (worst), will be calculated.
|
Change in subjective answers of health related quality of life from baseline, to 6 mounts and to 12 mounts.
|
Shoulder function
Time Frame: Baseline and after 12 months
|
A physiotherapist will assess the active shoulder range of motion, categorized as normal, active range of motion >50% of perceived motion, or active range of motion <50% of perceived motion.
shoulder flexion, extension, abduction, and rotation will be measured.
|
Baseline and after 12 months
|
Physical Activity, assessed by use of questionnaire
Time Frame: Change in subjective answers of everyday activity from baseline, to 6 mounts and to 12 mounts.
|
Physical Activity will be subjective measured by use of a questionnaire regarding participants' everyday activity.
Participants range their activity in several sports activities from never (1) to several days a week (4).The questionnaire is previous used in a national survey study regarding physical activity among children and adolescents in Norway.
|
Change in subjective answers of everyday activity from baseline, to 6 mounts and to 12 mounts.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Johan Kibsgård, MD PhD, Oslo University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Genetic Diseases, Inborn
- Musculoskeletal Diseases
- Neurodegenerative Diseases
- Neoplasms, Nerve Tissue
- Bone Diseases
- Heredodegenerative Disorders, Nervous System
- Neoplastic Syndromes, Hereditary
- Spinal Curvatures
- Bone Diseases, Developmental
- Nerve Sheath Neoplasms
- Neurocutaneous Syndromes
- Neurofibroma
- Scoliosis
- Spinal Diseases
- Neurofibromatoses
- Osteochondrodysplasias
Other Study ID Numbers
- OUHRH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scoliosis
-
Manhattan Physical Medicine and Rehabilitation,...RecruitingScoliosis Idiopathic | Scoliosis; Adolescence | Scoliosis; Lumbar RegionUnited States
-
Stanford UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Not yet recruitingScoliosis Idiopathic | Spondylolisthesis | Scoliosis; Adolescence | Kyphosis | Juvenile; Scoliosis | Scoliosis;CongenitalUnited States
-
Seattle Children's HospitalJohns Hopkins University; Duke University; Vanderbilt University; University of... and other collaboratorsRecruitingScoliosis Idiopathic | Spondylolisthesis | Scoliosis; Adolescence | Kyphosis | Juvenile; Scoliosis | Scoliosis;CongenitalUnited States
-
Children's National Research InstituteNational Institute for Biomedical Imaging and Bioengineering (NIBIB); Kitware...RecruitingScoliosis Idiopathic | Scoliosis; JuvenileUnited States
-
University of HaifaRecruitingScoliosis Idiopathic | Scoliosis; AdolescenceIsrael
-
University of PecsCompletedScoliosis Idiopathic | Scoliosis, SevereHungary
-
Istituto Scientifico Italiano Colonna VertebraleCompletedScoliosis Idiopathic | Scoliosis; AdolescenceItaly
-
Istituto Scientifico Italiano Colonna VertebraleRecruiting
-
Stanford UniversityRecruitingScoliosis; Juvenile | Scoliosis; AdolescenceUnited States
-
Istanbul Gelisim UniversityCompletedScoliosis Idiopathic | Scoliosis; AdolescenceTurkey